Clinical Trials Browser

Interventional × Edema × Breast × Clear all

NCT07365618 2026-01-26

LymFit

Phase NA Not yet recruiting

Breast Cancer Lymphedema, Breast Neoplasms, Edema, Motor Activity

NCT02411656 2026-01-23

Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy

Phase 2 Active not recruiting

71 enrolled 11 charts

Edema, Erythema, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02876107 2025-10-10

Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer

Phase 2 Active not recruiting

Breast Neoplasms, Edema, Erythema, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03477565 2018-03-26

BREASTAPE

Phase NA Unknown

Breast Neoplasms, Edema, Seroma

NCT02158832 2017-08-30

Acupuncture for Lymphedema Secondary to Breast Cancer Treatment

Phase NA Withdrawn

Breast Neoplasms, Edema, Lymphedema, Neoplasms

NCT02707835 2016-03-17

Edema Control in Patients With Breast Cancer-comparison of Manual Lymph Drainage and Epidermis Fascia Taping

Phase NA Unknown

Breast Neoplasms, Edema